A new dual-modal, non-invasive detection technique could make it easier—and faster—to differentiate between melanoma skin cancer and benign lesions.
2025
First Patient Dosed With CX-801 Plus Keytruda in Metastatic Melanoma
The first patient has been dosed with CX-801 in combination with Keytruda (pembrolizumab) in an ongoing phase 1 dose escalation study, which is evaluating the safety and initial clinical activity of the agent in patients with metastatic melanoma, according to a news release from CytomX Therapeutics.
AMERICAN SKIN ASSOCIATION CELEBRATES MELANOMA AWARENESS MONTH
As a part of a robust national campaign, American Skin Association (ASA) is pleased to join with all those supporting skin health to celebrate Melanoma Awareness Month this May.
Rocket Doctor Partners with Melanoma Canada to Expand Access to Follow-Up Care for At-Risk Patients
New collaboration will connect patients flagged during mobile skin cancer screenings with Rocket Doctor physicians across Ontario, Alberta, and British Columbia